07:57 AM EST, 12/15/2025 (MT Newswires) -- Immunome ( IMNM ) said Monday that its global pivotal phase 3 trial evaluating varegacestat, an investigational gamma secretase inhibitor, in patients with progressing desmoid tumors met its primary endpoint of improving progression-free survival. The oral, once-daily treatment demonstrated a statistically significant and clinically meaningful 84% reduction in the risk of disease progression...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

07:56 AM EST, 12/15/2025 (MT Newswires) -- Opendoor Technologies ( OPEN ) said Monday that it has named Christy Schwartz as permanent chief financial officer, starting Jan. 1, 2026. Schwartz, who has served as interim CFO, was selected after an external search, the company said. Opendoor ( OPEN ) also named Lucas Matheson as president, starting Dec. 22. Matheson, former...

07:55 AM EST, 12/15/2025 (MT Newswires) -- Zoetis ( ZTS ) said Monday it plans to offer $1.75 billion worth of convertible senior notes due 2029 in a private offering. Zoetis ( ZTS ) said it also intends to grant initial purchasers a 13-day option to buy up to $250 million worth of additional notes. Zoetis ( ZTS ) said...